.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Fetal growth restriction is a heterogeneous condition, and diagnosis based only on a single estimated fetal weight can miss important patterns of placental insufficiency. Studies of umbilical-artery and cerebroplacental Doppler show that abnormal placental resistance and redistribution can identify fetuses at higher risk of adverse outcomes even when estimated fetal weight alone is not profoundly low. For maternal-fetal medicine, the practical lesson is to integrate serial growth, amniotic-fluid assessment and Doppler findings with gestational age and maternal risk factors. Surveillance should then be individualized according to severity and trajectory. An abnormal Doppler does not by itself dictate immediate delivery; the decision depends on gestational age, fetal testing, maternal status and local protocol. This approach helps avoid both delayed delivery of compromised fetuses and unnecessary intervention in constitutionally small but healthy pregnancies.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Fetal growth restriction is a heterogeneous condition, and diagnosis based only on a single estimated fetal weight can miss important patterns of placental insufficiency. Studies of umbilical-artery and cerebroplacental Doppler show that abnormal placental resistance and redistribution can identify fetuses at higher risk of adverse outcomes even when estimated fetal weight alone is not profoundly low. For maternal-fetal medicine, the practical lesson is to integrate serial growth, amniotic-fluid assessment and Doppler findings with gestational age and maternal risk factors. Surveillance should then be individualized according to severity and trajectory. An abnormal Doppler does not by itself dictate immediate delivery; the decision depends on gestational age, fetal testing, maternal status and local protocol. This approach helps avoid both delayed delivery of compromised fetuses and unnecessary intervention in constitutionally small but healthy pregnancies.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
